Nadir Mahmood
President and Principal Accounting & Financial OfficerDr. Nadir Mahmood, Ph.D., has been President of Nkarta, Inc. since July 2024 and is its principal accounting officer and principal financial officer from March 31, 2025. He had been Chief Financial and Business Officer at Nkarta, Inc. since October 5, 2020 until June 30, 2023. He served as Chief Business Officer at Nkarta, Inc. since September 2019 until October 2020. Dr. Mahmood joined Nkarta in May 2018 with experience in corporate development, research and finance in the biopharmaceutical and financial industries. He served as CEO & Director at Rezo Therapeutics, Inc. since September 2023. Dr. Mahmood, who previously was Senior Vice President of Corporate Development from May 2018 to September 2019. Dr. Mahmood served as the Senior Director, Corporate Development at Second Genome, Inc. from December 2016 to May 2017 and as the Director of External Alliances at Second Genome, Incorporated from March 2012 to December 2016. Prior to joining Nkarta in 2018, Dr. Mahmood headed corporate development at Second Genome where he was responsible for establishing strategy and partnerships across the company’s portfolio of programs and oversaw all intellectual property matters. Earlier in his career, he was Staff Scientist at Kythera Biopharmaceuticals (acquired by Allergan) from July 2007 to July 2009, overseeing preclinical research for the company’s lead molecule, Kybella®. Prior to joining Goldman Sachs, he conducted postdoctoral research as a Research Associate at the Scripps Research Institute in La Jolla, CA from August 2009 to January 2011. He was an independent consultant From September 2011 to March 2012. Dr. Mahmood has also worked as an Equity Research Fellow in Global Investment Research at Goldman Sachs Incorporated from January 2011 to July 2011 and consulted for early stage companies in the life sciences and clean energy sectors. He has a BS degree in Biochemistry from the University of Texas at Austin, a Ph.D degree in Cell Regulation from the University of Texas Southwestern Medical Center and completed postdoctoral research at the Scripps Research Institute in La Jolla, CA.
Positions
- Company NameNkarta, Inc.Stock CodeNKTXPositionPresident and Principal Accounting & Financial Officer
